John Chan

John Chan is a scientist with expertise in process development and CMC in AAV gene therapy. They currently serve as a Senior Advisor in Gene Therapy Discovery and Platform Research at Eli Lilly, where they have held various roles since 2022. John previously worked as a Senior Scientist, Process Development at Prevail Therapeutics and has also held significant positions at Brammer Bio and Dartmouth-Hitchcock. They are pursuing a Master of Science degree at the University of New Hampshire while holding a Bachelor of Science degree from Boston College.